newsfilter
← Latest News
GlobeNewswire·

Verona Pharma to Host Investor Update on Commercialization Preparation for Ensifentrine on October 18, 2023

LONDON and RALEIGH, N.C., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma" or the "Company"), announces it will hold an Investor Update in New York City for investors and analysts on